| 11/16/2026 3:35 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/12/2026 3:38 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/12/2026 3:38 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/10/2026 3:34 PM | PATUSKY CHRISTOPHER (1231427) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/10/2026 3:35 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/10/2026 3:35 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/09/2026 4:41 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/09/2026 4:00 PM | PATUSKY CHRISTOPHER (1231427) Reporting United Therapeutics (1082554) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/06/2026 3:54 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/06/2026 3:57 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2026 4:15 PM | MAHON PAUL A (1231589) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for UTHR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for United Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 11/05/2026 4:21 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2026 4:21 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2026 3:21 PM | MAHON PAUL A (1231589) Reporting United Therapeutics (1082554) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/04/2026 3:46 PM | ROTHBLATT MARTINE A (1106578) Filed by United Therapeutics (1082554) Subject | Form SCHEDULE 13G/A | |
| 11/04/2026 3:38 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/04/2026 5:30 AM | United Therapeutics (1082554) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/04/2026 5:31 AM | United Therapeutics (1082554) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/02/2026 3:34 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/02/2026 3:40 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/30/2026 3:30 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/29/2026 3:30 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/28/2026 3:30 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/27/2026 3:30 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/26/2026 3:31 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/23/2026 3:35 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2026 3:36 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2026 6:00 AM | United Therapeutics (1082554) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/21/2026 3:34 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/20/2026 3:36 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/19/2026 3:33 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/16/2026 3:34 PM | MAHON PAUL A (1231589) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/16/2026 3:35 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/15/2026 3:22 PM | MAHON PAUL A (1231589) Reporting United Therapeutics (1082554) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/15/2026 3:34 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/14/2026 3:31 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/14/2026 6:00 AM | United Therapeutics (1082554) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/13/2026 3:30 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/13/2026 3:31 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/09/2026 3:31 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/08/2026 4:28 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Your Copy is on Hold (Claim it now) (Ad) James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on Elon Musk's next big industry play.
He estimates it could create 1.8 million new millionaires in the coming years, and shows how to position in the company at its center for under $60.
Inside: the company's name and ticker, plus an FCC filing James believes reveals Elon's plan to take over a $25 trillion industry. He also flags December 8 as a key date. Claim your copy of James Altucher's new Elon Musk report today. |
| 10/07/2026 3:35 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/06/2026 3:32 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/02/2026 3:31 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/01/2026 4:30 PM | MAHON PAUL A (1231589) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/01/2026 4:20 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/01/2026 4:22 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/01/2026 3:37 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/01/2026 3:07 PM | MAHON PAUL A (1231589) Reporting United Therapeutics (1082554) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/30/2026 3:30 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/29/2026 3:33 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/28/2026 3:30 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/25/2026 3:31 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/24/2026 3:31 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/23/2026 3:30 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/22/2026 3:33 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/21/2026 3:44 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/18/2026 3:40 PM | MAHON PAUL A (1231589) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/18/2026 3:41 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/17/2026 3:43 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/17/2026 3:19 PM | MAHON PAUL A (1231589) Reporting United Therapeutics (1082554) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/16/2026 3:35 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2026 3:33 PM | Mesa Nilda (1756697) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2026 3:34 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/11/2026 3:34 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/10/2026 3:31 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/09/2026 3:33 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/08/2026 4:12 PM | United Therapeutics (1082554) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/08/2026 3:31 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/04/2026 3:31 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/03/2026 3:31 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/03/2026 3:32 PM | MAHON PAUL A (1231589) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/02/2026 3:34 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/01/2026 3:54 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/01/2026 3:33 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/31/2026 3:34 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/27/2026 3:34 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/26/2026 3:30 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/24/2026 3:30 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/21/2026 3:43 PM | MAHON PAUL A (1231589) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/21/2026 3:44 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/20/2026 5:45 PM | MAHON PAUL A (1231589) Reporting United Therapeutics (1082554) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/20/2026 3:37 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/19/2026 3:33 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/17/2026 3:34 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/14/2026 6:00 AM | ROTHBLATT MARTINE A (1106578) Filed by United Therapeutics (1082554) Subject | Form SCHEDULE 13G/A | |
| 08/13/2026 4:09 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/12/2026 3:30 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/11/2026 3:30 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/10/2026 3:38 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/06/2026 3:34 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
My public warning after 55 years of watching the markets (Ad) Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit.
Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks. See Martin Weiss's full warning before this risk spreads further |
| 08/06/2026 3:35 PM | MAHON PAUL A (1231589) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/05/2026 3:36 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/05/2026 5:31 AM | United Therapeutics (1082554) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/05/2026 5:33 AM | United Therapeutics (1082554) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/04/2026 3:32 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/03/2026 3:41 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/03/2026 3:32 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/31/2026 3:18 PM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/30/2026 6:58 AM | ROTHBLATT MARTINE A (1106578) Reporting United Therapeutics (1082554) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |